CX-1300 series (Cylene)

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NameCX-1300 series (Cylene)

Drug Alias NameDNA quadruplex regulators (Cylene)c-myc expression regulators (Cylene)c-myc expression regulators (Cyternex)telomerase inhibitors (Cyternex)CX-myc +[12]

ClassificationSmall molecules

Mechanisms of ActionTranscription factors inhibitors

TargetsTranscription factors

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCylene Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCylene Pharmaceuticals Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A